Back to Search
ANDREW PETRILLI, MD
MD
Critical Care Medicine (Internal Medicine) Physician
NPI: 1629531918IndividualAccepts Medicare
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) PhysicianPrimary
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
2023-00160(NC)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 2019
Research & Publications (20)
Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia.
PMID 17253640·Pediatr Blood Cancer·2007
3-trial
Results of the Brazilian Osteosarcoma Treatment Group Studies III and IV: prognostic factors and impact on survival.
PMID 16505436·J Clin Oncol·2006
3-trial
Evaluation of ticarcillin/clavulanic acid versus ceftriaxone plus amikacin for fever and neutropenia in pediatric patients with leukemia and lymphoma.
PMID 12959681·Braz J Infect Dis·2003
3-trial
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
PMID 10657866·Med Pediatr Oncol·2000
3-trial
Aprepitant in adolescent patients for prevention of chemotherapy-induced nausea and vomiting: a randomized, double-blind, placebo-controlled study of efficacy and tolerability.
PMID 18985740·Pediatr Blood Cancer·2009
2-rct
A simplified minimal residual disease polymerase chain reaction method at early treatment points can stratify children with acute lymphoblastic leukemia into good and poor outcome groups.
PMID 19483156·Haematologica·2009
4-observational
mRNA expression profile of multidrug resistance genes in childhood acute lymphoblastic leukemia. Low expression levels associated with a higher risk of toxic death.
PMID 19672972·Pediatr Blood Cancer·2009
4-observational
Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
PMID 19597646·J Microbiol Immunol Infect·2009
4-observational
Prognostic factors and outcomes for osteosarcoma: an international collaboration.
PMID 19349163·Eur J Cancer·2009
8-other
Risk factors for death in children and adolescents with cancer and sepsis/septic shock.
PMID 18797197·J Pediatr Hematol Oncol·2008
8-other
Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients.
PMID 18754720·Photomed Laser Surg·2008
2-rct
TNF-alpha, TNF-beta, IL-6, IL-10, PECAM-1 and the MPO inflammatory gene polymorphisms in osteosarcoma.
PMID 17483704·J Pediatr Hematol Oncol·2007
8-other
Leptin assessment in acute lymphocytic leukemia survivors: role of cranial radiotherapy?
PMID 17984698·J Pediatr Hematol Oncol·2007
8-other
Expression of major vault protein gene in osteosarcoma patients.
PMID 17415755·J Orthop Res·2007
8-other
Left ventricular systolic function assessed by echocardiography in children and adolescents with osteosarcoma treated with doxorubicin alone or in combination with dexrazoxane.
PMID 17262115·Arq Bras Cardiol·2006
3-trial
["You will not believe us, but we have many" defective births, children, mothers and tales].
PMID 17992851·Med Secoli·2006
8-other
Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma.
PMID 17022822·BMC Cancer·2006
4-observational
Contribution to the treatment of nausea and emesis induced by chemotherapy in children and adolescents with osteosarcoma.
PMID 16878187·Sao Paulo Med J·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL CENTER BOULEVARD
WINSTON SALEM, NC 27157 - Phone
- (336) 716-6533
Quick Facts
- NPI
- 1629531918
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 7
- Publications
- 20
Are you this provider?
Claim Your Profile